Levofloxacin Injection, Solution
Product Images NDC 0143-9316

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0143-9316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levofloxacin Structure (Levofloxacin Injection In 5 Percent Dextrose Nov 1)

Chemical structure of Levofloxacin, depicting its molecular arrangement including rings, functional groups, and a water of hydration (1/2 H2O). The structure highlights key features such as fluorine, carboxylic acid, and methylated nitrogen-containing rings.*

FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Injection In 5 Percent Dextrose Nov 2)

A pharmacokinetic graph comparing plasma concentration (µg/mL) over time (hours) for 750 mg Levofloxacin administered orally as a tablet versus intravenously as a 90-minute infusion. The graph shows concentration changes up to 36 hours post-dose for both routes.*

FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Injection In 5 Percent Dextrose Nov 3)

A line graph comparing plasma concentration (µg/mL) of Levofloxacin over time (hours) after 500 mg dosing via oral tablet and intravenous injection. The graph shows plasma concentration on the y-axis and time (0 to 36 hours) on the x-axis for both administration routes.*

FDA Label Image

0143931501 (Levofloxacin Injection In 5 Percent Dextrose Nov 4)

Levofloxacin Injection in 5% Dextrose, 250 mg in 50 mL solution, for intravenous infusion. The label indicates infusion over 60 minutes and includes preparation and storage instructions. Manufactured by Hikma Farmacêutica Portugal and distributed by West-Ward A Hikma Company, Eatontown, NJ. The label also highlights single dose container use and proper handling until infusion.*

FDA Label Image

0143931601 (Levofloxacin Injection In 5 Percent Dextrose Nov 5)

Levofloxacin Injection in 5% Dextrose 500 mg in 100 mL solution for intravenous infusion. The label indicates a 5 mg/mL concentration and specifies use over 60 minutes. It includes storage instructions, usage warnings, and manufacturer details for Hikma Pharmaceuticals USA Inc. The label also features lot and expiration date fields and a barcode with NDC 0143-9316-01.*

FDA Label Image

0143931701 (Levofloxacin Injection In 5 Percent Dextrose Nov 6)

Levofloxacin Injection in 5% Dextrose 750 mg in 150 mL intravenous solution. The label provides directions for intravenous infusion over 90 minutes and storage instructions. The container is single-dose and should be used only if the solution is clear and the container undamaged. Manufactured by Hikma Farmaceutica, distributed by West-Ward a Hikma Company.*

FDA Label Image

Layout 1 (Levofloxacin Injection In 5 Percent Dextrose Nov 7)

A label from Hikma Pharmaceuticals USA Inc. for Levofloxacin injection solution. The label displays a QR code alongside text with GTIN, serial number, expiration date placeholder, and lot number placeholder information. Strength and volume are not shown on the label portion in this image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.